US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development.
Saved in:
| Title: | US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development. |
|---|---|
| Authors: | Morant AV; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark., Vestergaard HT; Regulatory Strategy, H. Lundbeck A/S, Copenhagen, Denmark., Lassen AB; Patient Insights, H. Lundbeck A/S, Copenhagen, Denmark., Navikas V; Medical Affairs, H. Lundbeck A/S, Copenhagen, Denmark. |
| Source: | Clinical and translational science [Clin Transl Sci] 2020 Jul; Vol. 13 (4), pp. 652-664. Date of Electronic Publication: 2020 Mar 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32043310 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Morant+AV%22">Morant AV</searchLink>; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Vestergaard+HT%22">Vestergaard HT</searchLink>; Regulatory Strategy, H. Lundbeck A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Lassen+AB%22">Lassen AB</searchLink>; Patient Insights, H. Lundbeck A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Navikas+V%22">Navikas V</searchLink>; Medical Affairs, H. Lundbeck A/S, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2020 Jul; Vol. 13 (4), pp. 652-664. <i>Date of Electronic Publication: </i>2020 Mar 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32043310 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.12755 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 652 Titles: – TitleFull: US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Morant AV – PersonEntity: Name: NameFull: Vestergaard HT – PersonEntity: Name: NameFull: Lassen AB – PersonEntity: Name: NameFull: Navikas V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2020 Jul Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1752-8062 Numbering: – Type: volume Value: 13 – Type: issue Value: 4 Titles: – TitleFull: Clinical and translational science Type: main |
| ResultId | 1 |
